News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
645,900 Results
Type
Article (61289)
Company Profile (69)
Press Release (584542)
Multimedia
Podcasts (59)
Webinars (13)
Section
Business (174105)
Career Advice (2729)
Deals (32554)
Drug Delivery (97)
Drug Development (76940)
Employer Resources (150)
FDA (14948)
Job Trends (13882)
News (305500)
Policy (29009)
Tag
Academia (2893)
Academic (2)
Accelerated approval (6)
Adcomms (22)
Allergies (88)
Alliances (43304)
ALS (88)
Alzheimer's disease (1320)
Antibody-drug conjugate (ADC) (109)
Approvals (14964)
Artificial intelligence (264)
Autoimmune disease (23)
Automation (15)
Bankruptcy (290)
Best Places to Work (10853)
BIOSECURE Act (16)
Biosimilars (101)
Biotechnology (51)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (273)
Cancer (2182)
Cardiovascular disease (165)
Career advice (2312)
Career pathing (33)
CAR-T (154)
Cell therapy (429)
Cervical cancer (20)
Clinical research (62568)
Collaboration (784)
Company closure (1)
Compensation (326)
Complete response letters (20)
COVID-19 (2571)
CRISPR (43)
C-suite (260)
Cystic fibrosis (100)
Data (2150)
Decentralized trials (2)
Denatured (25)
Depression (43)
Diabetes (252)
Diagnostics (6179)
Digital health (19)
Diversity (9)
Diversity, equity & inclusion (39)
Drug discovery (113)
Drug pricing (97)
Drug shortages (23)
Duchenne muscular dystrophy (86)
Earnings (60345)
Editorial (39)
Employer branding (18)
Employer resources (132)
Events (94638)
Executive appointments (760)
FDA (16204)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (747)
Gene editing (109)
Generative AI (20)
Gene therapy (299)
GLP-1 (665)
Government (4461)
Grass and pollen (6)
Guidances (64)
Healthcare (18228)
Huntington's disease (19)
IgA nephropathy (25)
Immunology and inflammation (108)
Indications (28)
Infectious disease (2704)
Inflammatory bowel disease (136)
Inflation Reduction Act (8)
Influenza (53)
Intellectual property (96)
Interviews (526)
IPO (14877)
IRA (38)
Job creations (3414)
Job search strategy (1941)
Kidney cancer (10)
Labor market (30)
Layoffs (503)
Leadership (22)
Legal (6448)
Liver cancer (69)
Lung cancer (304)
Lymphoma (145)
Machine learning (7)
Management (53)
Manufacturing (276)
MASH (63)
Medical device (12660)
Medtech (12665)
Mergers & acquisitions (18255)
Metabolic disorders (632)
Multiple sclerosis (77)
NASH (13)
Neurodegenerative disease (84)
Neuropsychiatric disorders (26)
Neuroscience (1837)
NextGen: Class of 2025 (6373)
Non-profit (4316)
Now hiring (12)
Obesity (321)
Opinion (232)
Ovarian cancer (71)
Pain (91)
Pancreatic cancer (79)
Parkinson's disease (141)
Partnered (21)
Patents (234)
Patient recruitment (112)
Peanut (50)
People (59583)
Pharmaceutical (20)
Pharmacy benefit managers (15)
Phase I (19698)
Phase II (27609)
Phase III (20147)
Pipeline (1142)
Policy (125)
Postmarket research (2477)
Preclinical (8405)
Press Release (67)
Prostate cancer (107)
Psychedelics (27)
Radiopharmaceuticals (249)
Rare diseases (360)
Real estate (6000)
Recruiting (61)
Regulatory (20154)
Reports (33)
Research institute (2397)
Resumes & cover letters (405)
Rett syndrome (5)
RNA editing (3)
RSV (35)
Schizophrenia (68)
Series A (131)
Series B (86)
Service/supplier (9)
Sickle cell disease (51)
Special edition (10)
Spinal muscular atrophy (146)
Sponsored (29)
Startups (3342)
State (1)
Stomach cancer (9)
Supply chain (54)
Tariffs (26)
The Weekly (32)
Vaccines (664)
Venture capitalists (34)
Weight loss (202)
Women's health (30)
Worklife (19)
Date
Today (46)
Last 7 days (816)
Last 30 days (2413)
Last 365 days (30416)
2025 (10161)
2024 (32291)
2023 (36360)
2022 (46645)
2021 (51635)
2020 (50839)
2019 (44910)
2018 (34114)
2017 (30768)
2016 (30122)
2015 (35480)
2014 (28422)
2013 (24989)
2012 (26261)
2011 (26534)
2010 (24988)
Location
Africa (872)
Alabama (54)
Alaska (6)
Arizona (171)
Arkansas (14)
Asia (38132)
Australia (6859)
California (5557)
Canada (1855)
China (487)
Colorado (248)
Connecticut (259)
Delaware (140)
Europe (89543)
Florida (848)
Georgia (199)
Idaho (56)
Illinois (548)
India (25)
Indiana (279)
Iowa (10)
Japan (153)
Kansas (95)
Kentucky (24)
Louisiana (10)
Maine (61)
Maryland (828)
Massachusetts (4016)
Michigan (222)
Minnesota (338)
Mississippi (2)
Missouri (87)
Montana (29)
Nebraska (23)
Nevada (57)
New Hampshire (61)
New Jersey (1640)
New Mexico (29)
New York (1629)
North Carolina (956)
North Dakota (9)
Northern California (2407)
Ohio (194)
Oklahoma (15)
Oregon (36)
Pennsylvania (1234)
Puerto Rico (12)
Rhode Island (31)
South America (1177)
South Carolina (17)
South Dakota (1)
Southern California (2127)
Tennessee (95)
Texas (848)
United States (21242)
Utah (172)
Virginia (143)
Washington D.C. (50)
Washington State (511)
West Virginia (3)
Wisconsin (60)
645,900 Results for "university of frankfurt".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Neural Therapeutics Commences Trading on Frankfurt Stock Exchange
March 31, 2025
·
5 min read
Press Releases
Moss Genomics Inc. Announces Successful German Listing on the Frankfurt Stock Exchange (FSE)
January 14, 2025
·
5 min read
Press Releases
Wiley to Reveal Key Insights and AI-Driven Innovations at Frankfurt Book Fair
October 16, 2024
·
4 min read
Press Releases
Neural Therapeutics Strengthens IP Portfolio With a Patent Application
Treatment of Major DSM-5 Disorders, Including Addiction, Depression and Anxiety, With Sub-Hallucinogenic Mescaline Doses Extraction Technology Delivering Higher Yields and Greater Purity Frankfurt Stock Exchange Ticker Symbol Changed to “HANF” Extension of LOI with CWE European Holdings (dba Hanf.com)
April 14, 2025
·
7 min read
ME Therapeutics Holdings Inc. Announces Listing on the Frankfurt Stock Exchange (FSE) and the Completion of Its Redesigned Website
ME Therapeutics Holdings Inc. (CSE: METX), a preclinical stage biotechnology company working on novel cancer fighting drugs in the field of Immuno-Oncology, is pleased to announce that the Company’s common shares are now listed on the Frankfurt Stock Exchange (FSE) under the symbol Q9T.
December 11, 2023
·
3 min read
Biotech Bay
Adona Medical’s Next-Generation Heart Failure Management Platform Showcased at CSI Frankfurt 2023 Conference
Adona Medical announced that its next-generation heart failure management platform was featured at the CSI Frankfurt 2023 conference.
July 10, 2023
·
3 min read
Deals
Universal Ibogaine Announces Frankfurt Stock Exchange Listing
Universal Ibogaine Inc. is pleased to announce that its common shares have been approved for trading on the Frankfurt Stock Exchange, or Bourse Frankfurt (the “FSE”) under the ticker symbol “JC4".
April 6, 2022
·
5 min read
Business
QIAGEN announces partnership with Penn State University to advance microbiome sciences
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a first-in-kind collaboration with Penn State University in the United States to create a shared research and education facility for the fast-developing microbiome sciences.
January 25, 2024
·
9 min read
SINOVAC to Showcase Products at CPHI Frankfurt
Sinovac Biotech Ltd. announced that the Company will participate in CPHI Frankfurt, one of the world’s largest pharmaceutical exhibitions, from 1st to 3rd of November, in Frankfurt, Germany.
October 28, 2022
·
2 min read
Biotech Beach
David Friend, Ph.D., Chief Scientific Officer of Daré Bioscience, Inc., to Present at the Global Pharma & Drug Delivery Summit 2023 to be held April 24-26, 2023 in Frankfurt, Germany
Daré Bioscience, Inc., a leader in women’s health innovation, announced that the company’s Chief Scientific Officer, David Friend, Ph.D., will be presenting in the Keynote Forum of the Global Pharma & Drug Delivery Summit 2023 to be held April 24-26, 2023 in Frankfurt, Germany.
April 19, 2023
·
9 min read
1 of 64,590
Next
